Cargando…
Aberrant cystatin-C expression in blood from patients with breast cancer is a suitable marker for monitoring tumor burden
The present study was performed to evaluate the efficacy of circulating cystatin-C as a tumor monitoring biomarker at different clinical time points in patients with breast cancer over a long-term follow-up period. In addition, the secretory rate of circulating cystatin-C from cancer tissue was inve...
| Autores principales: | , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
D.A. Spandidos
2018
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6176264/ https://www.ncbi.nlm.nih.gov/pubmed/30344712 http://dx.doi.org/10.3892/ol.2018.9380 |